Securities Code: 002038
Securities Abbreviation: Shuanglu Pharmaceutical
Announcement Number: 2026-002
Announcement of Abnormal Stock Trading Fluctuations of Beijing Shuanglu Pharmaceutical Co., Ltd.
The company and all members of the board of directors guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
I. Basic Situation of Abnormal Stock Trading
Beijing Shuanglu Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") experienced its stock (Securities Code: 002038, Securities Abbreviation: Shuanglu Pharmaceutical) closing price increase exceeding 20% cumulatively over three consecutive trading days on March 27, 2026, and March 31, 2026. This situation falls under the category of abnormal stock trading fluctuations according to the relevant provisions of the Shenzhen Stock Exchange Trading Rules.
II. Relevant Situations Verified by the Company
In response to the abnormal fluctuations in stock trading, the Company has verified relevant issues with its controlling shareholder and actual controller, and the following situations are explained: